118 related articles for article (PubMed ID: 1862741)
1. Comparative effects of two potentiating peptides (KPP and BPP9a) on kinin-induced rat paw edema.
Fernandes PD; Guimarães JA; Assreuy J
Agents Actions; 1991 Mar; 32(3-4):182-7. PubMed ID: 1862741
[TBL] [Abstract][Full Text] [Related]
2. Comparative study on the mechanism of bradykinin potentiation induced by bradykinin-potentiating peptide 9a, enalaprilat and kinin-potentiating peptide.
Rodrigues MS; Schaffel R; Assreuy J
Eur J Pharmacol; 1992 Jun; 216(3):357-62. PubMed ID: 1330581
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological properties of a new kinin-potentiating peptide generated from human serum proteins.
Assreuy J; Almeida AA; Guimarães JA
Eur J Pharmacol; 1989 Sep; 168(2):231-7. PubMed ID: 2606151
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a new kinin potentiating peptide obtained from human plasma proteins.
Assreuy-Filho J; Almeida AA; Guimarães JA
Braz J Med Biol Res; 1988; 21(3):453-5. PubMed ID: 3228625
[TBL] [Abstract][Full Text] [Related]
5. Effect of stretching on the sensitivity of the guinea pig ileum to bradykinin and on its modification by bradykinin potentiating peptides.
Shimuta SI; Sabia EB; Paiva AC; Paiva TB
Eur J Pharmacol; 1981 Apr; 70(4):551-8. PubMed ID: 7238576
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of bradykinin effects and inhibition of kininase activity in isolated smooth muscle.
Schaffel R; Rodrigues MS; Assreuy J
Can J Physiol Pharmacol; 1991 Jul; 69(7):904-8. PubMed ID: 1659490
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of B1 receptor mediating des-Arg9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin.
Campos MM; Souza GE; Calixto JB
Br J Pharmacol; 1996 Mar; 117(5):793-8. PubMed ID: 8851492
[TBL] [Abstract][Full Text] [Related]
8. Bradykinin potentiating and sensitizing activities of new synthetic analogues of snake venom peptides.
Sabia EB; Tominaga M; Paiva AC; Paiva TB
J Med Chem; 1977 Dec; 20(12):1679-81. PubMed ID: 592335
[TBL] [Abstract][Full Text] [Related]
9. Involvement of B1 and B2 receptors in bradykinin-induced rat paw oedema.
Campos MM; Calixto JB
Br J Pharmacol; 1995 Mar; 114(5):1005-13. PubMed ID: 7780633
[TBL] [Abstract][Full Text] [Related]
10. A new structurally atypical bradykinin-potentiating peptide isolated from Crotalus durissus cascavella venom (South American rattlesnake).
Lopes DM; Junior NE; Costa PP; Martins PL; Santos CF; Carvalho ED; Carvalho MD; Pimenta DC; Cardi BA; Fonteles MC; Nascimento NR; Carvalho KM
Toxicon; 2014 Nov; 90():36-44. PubMed ID: 25091347
[TBL] [Abstract][Full Text] [Related]
11. Structure and effects of a kinin potentiating fraction F (AppF) isolated from Agkistrodon piscivorus piscivorus venom.
Ferreira LA; Möllring T; Lebrun FL; Raida M; Znottka R; Habermehl GG
Toxicon; 1995 Oct; 33(10):1313-9. PubMed ID: 8599182
[TBL] [Abstract][Full Text] [Related]
12. Conversion of T-kinin to bradykinin by the rat kidney.
Vieira MA; Moreira MF; Maack T; Guimarães JA
Biochem Pharmacol; 1994 Apr; 47(9):1693-9. PubMed ID: 8185685
[TBL] [Abstract][Full Text] [Related]
13. [Potentiative effects of angiotensin converting enzyme inhibitors on carrageenan-induced edema in rats].
Suda H; Yamauchi H; Iso T
Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):517-23. PubMed ID: 6298082
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary metabolism of bradykinin analogues and the contribution of angiotensin converting enzyme to bradykinin inactivation in isolated lungs.
Bakhle YS
Br J Pharmacol; 1977 Jan; 59(1):123-8. PubMed ID: 189870
[TBL] [Abstract][Full Text] [Related]
15. Absence of effect of chronic angiotensin II type 1 receptor blockade on endogenous kinin concentrations-induced paw edema model in the rat.
Blais C; Leclair P; Molinaro G; Adam A
Peptides; 1999; 20(3):343-52. PubMed ID: 10447092
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and properties of new bradykinin potentiating peptides.
Tominaga M; Stewart JM
J Med Chem; 1975 Feb; 18(2):130-3. PubMed ID: 1120978
[TBL] [Abstract][Full Text] [Related]
17. The C-type natriuretic peptide precursor of snake brain contains highly specific inhibitors of the angiotensin-converting enzyme.
Hayashi MA; Murbach AF; Ianzer D; Portaro FC; Prezoto BC; Fernandes BL; Silveira PF; Silva CA; Pires RS; Britto LR; Dive V; Camargo AC
J Neurochem; 2003 May; 85(4):969-77. PubMed ID: 12716428
[TBL] [Abstract][Full Text] [Related]
18. Rat paw edema induced by trimucase II, a kinin-releasing enzyme from Trimeresurus mucrosquamatus venom.
Wang JP; Teng CM
Eur J Pharmacol; 1988 Nov; 157(1):61-6. PubMed ID: 2466673
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of angiotensin converting enzyme and potentiation of bradykinin by retro-inverso analogues of short peptides and sequences related to angiotensin I and bradykinin.
Carmona AK; Juliano L
Biochem Pharmacol; 1996 Apr; 51(8):1051-60. PubMed ID: 8866827
[TBL] [Abstract][Full Text] [Related]
20. Roles of mast cells and PMN leukocytes in cardiotoxin-induced rat paw edema.
Wang JP; Teng CM
Eur J Pharmacol; 1989 Feb; 161(1):9-18. PubMed ID: 2721549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
